Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

OTHER 103 INDUSTRY 2 FED 2 OTHER_GOV 1

Study Type

Interventional 1

Sponsor

Conditions

Motor Activity 8 Breast Neoplasms 6 Neurologic Manifestations 1 Neoplasms 1 Mouth Neoplasms 1 Medulloblastoma 1 Lymphoma, Follicular 1 Lymphedema 1 Esophageal Neoplasms 1 Endometrial Neoplasms 1 Deglutition Disorders 1 Colorectal Neoplasms 1 Breast Cancer Lymphedema 1 Breast Cancer Female 1 Brain Neoplasms 1 Bipolar Disorder 1

Interventions

Drug Therapy 4 pembrolizumab 3 Thermography 2 Surveys and Questionnaires 2 Standard of Care 2 Quality of Life 2 Preoperative Exercise 2 Nivolumab 2 Moxibustion 2 Hematologic Tests 2 Cyclophosphamide 2 Chemoradiotherapy 2 vandetanib 1 sinovac COVID-19 vaccine 1 lenvatinib 1 ibrutinib 1 fludarabine 1 encorafenib 1 durvalumab 1 binimetinib 1 beta Carotene 1 avelumab 1 atezolizumab 1 Zoledronic Acid 1 Zinc 1 Vitamin E 1 Vascular Access Devices 1 Validation Studies as Topic 1 Urination 1 Ultraviolet Therapy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER_GOV × Neoplasms × Exercise × Clear all

NCT04990856 2021-08-05

EXETUMOR3

Turku University Hospital

Phase NA Unknown

Motor Activity, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡